Ally Bridge Group — Full Portfolio

CG Oncology develops an investigational oncolytic immunotherapy for urologic cancer patients, specifically targeting BCG-unresponsive non-muscle invasive bladder cancer.

BiotechHealthtechMedical Devices

AKArthur Kuan(Chairman and Chief Executive Officer)in

Co-investorsDEDecheng CapitalFOForesite CapitalLOLongitude CapitalPAPalm Drive CapitalRARA CapitalTCTCG Crossover+2 more

Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery.

BiotechHealthtechMedical DevicesSan Jose, US

LAUREN CRISTINA(Executive Officer)inSRSri Radhakrishnan(Chief Technology Officer)inMICHAEL BAKER(Executive Officer, Director)inGlendon E. French(Chief Executive Officer and Director)DSDerrick Sung(Chief Operating Officer and Chief Financial Officer)inGeoffrey Beran Rose(Chief Commercial Officer)

Co-investorsBABand of AngelsHEHealthCapKAKaiser Permanente VenturesLALatterell Venture PartnersMOMontreux Equity Partners

Rapid Micro Biosystems manufactures automated laboratory testing systems and consumables for pharmaceutical and cell therapy manufacturers to conduct microbiological quality control testing, replacing manual methods with platform-based analysis.

HealthtechLowell, US

Robert Spignesi(Executive Officer, Director)inStephen H. Delity(Executive Officer, Director)Michael J. Mullen(Executive Officer)

BoardDavid Hirsch(Director)Richard S. Kollender(Director)Fred Cohen(Director)

Co-investorsENEndeavour VisionLOLongitude CapitalXEXeraya Capital

LightForce develops generative braces using artificial intelligence and 3D printing technology to create individualized orthodontic appliances tailored to each patient.

Advanced ManufacturingAI & Machine LearningHardwareHealthtechMedical DevicesBoston, US

Alfred Griffin, DMD, PhD(Chief Product Officer / Founder)Dr. Lou Shuman, DMD, CAGS(Co-founder)ERErica Rogers(Chief Executive Officer)in

Co-investorsKLKleiner PerkinsAMAM VenturesDIDIAMAMatrixMAMatter Venture PartnersOMOmega Venture Partners+3 more

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

MSMurthy Simhambhatla(CEO)inDCDavid Chernoff(Chief Medical Officer (MD))YLYaakov Levine(PhD)inRSRohan Seth(Executive Officer)in

BoardBWBlake Wu(Director)inJMJuan-Pablo Mas(Director)in

Co-investorsNENew Enterprise Associates (NEA)NONorwest Venture PartnersTOTopspin PartnersCACatalio Capital Management, LPCICitta CapitalLILightstone Ventures+5 more

AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.

BiotechHealthtechMedical DevicesCambridge, US

AAAndrew Adamovich(Director)inPLPhilina Lee(Executive Officer, Director)inAPAaron Pickett(Executive Officer)in

BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)

Co-investorsBABain Capital Life SciencesCACatalio Capital Management, LPPRProto AxiomSASanofi VenturesSVSV Health InvestorsTETenmile+2 more

Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis.

HealthtechMedical DevicesMountain View, US

MBMatt Brokaw(CEO & President)inDerrick Sung(Executive Officer)inMSMatthew Salkeld(Executive Officer)IRIrina Ridley(Executive Officer)inAndre Cheng(Executive Officer)inFDFred Dinger(Executive Officer, Director)in

Co-investorsLALaunchCapitalOROrbiMedQUQuesta CapitalTATargeted Technology FundsHOHorizon

BiotechCincinnati, US

RSRobert Shalwitz(Executive Officer)JGJoseph Gardner(Founder)inDuane Nash(Director)Kevin Peters(Executive Officer)Steve Pakola(Executive Officer)Ian A.W. Howes(Executive Officer)

Co-investorsCICincyTechSOSofinnova VenturesOROrbiMed

BiotechSan Diego, US

FFFrancois Ferre(Director)MMMagda Marquet(Director)Jorge Garces(Executive Officer)inGreg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)

Co-investorsBIBioBritTETelegraph Hill PartnersVIVivo CapitalWUWuXi Healthcare Ventures

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.

BiotechDigital HealthMedical DevicesCambridge, US

DADAVID ARTHUR SCOTT(Executive Officer)inWINSTON XIA YAN(Executive Officer)FZFENG ZHANG(Director)ANNIE HAZLEHURST(Director)

BoardKCKEITH CRANDELL(Director)DRDAVID R. WALT(Director)in

Co-investorsARARCH Venture PartnersILIllumina VenturesONOno Venture Investment, Inc.TCTCG CrossoverJAJanus Henderson InvestorsRERevelation Partners+4 more

Biobeat develops a cuff-less, ambulatory blood pressure monitoring system built around a proprietary PPG sensor and a platform for tracking vital signs, aimed at helping physicians diagnose and manage hypertension.

Digital HealthHealthtechMedical Devices

ABArik B.(Founder)inABArik Ben Ishay(Founder & CEO)JMJohanan May(Founder, SVP & CTO)inISIsrael Sarussi(Founder, SVP R&D)inMGMichael Gioffredi(CCO)in

BoardRaymond W. Cohen(Chairman of the Board)

Co-investorsOROrbiMedRARaptor Group

Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared.

HealthtechMedical DevicesPleasanton, US

CBChris Buchko(Executive Officer)inDouglas Hughes(Executive Officer, Director)Jee Shin(Executive Officer, Director)inMark Kidd(Executive Officer)Joe Catanese(Executive Officer, Director)

BoardRDRyan Drant(Director)in

Co-investorsQUQuesta CapitalJAJanus Henderson Investors

Cardiac Dimensions develops medical technology to treat heart failure caused by functional mitral regurgitation (FMR), aiming to address underlying causes rather than symptoms.

BiotechHealthtechMedical DevicesKirkland, US

Frederick A. Stewart(Executive Officer, Director)RWRick Wypych(Executive Officer)in

BoardKurt Wheeler(Director)Nathan Every(Director)Douglas C. Fisher(Director)GBGerry Brunk(Director)in

Co-investorsAPAPERTURE Venture PartnersLULumira VenturesRERedbus VenturesCLClaret Capital PartnersJEJefferiesM.M.H. Carnegie & Co.

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

BiotechSan Mateo, US

GCGina Chapman(Executive Officer, Director)inAnup Radhakrishnan(Executive Officer)inCassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)

BoardAbraham Bassan(Director)

Co-investorsNENextech InvestRERed Tree VentureSASamsara BioCapitalJAJanus Henderson InvestorsPEPerceptive Xontogeny VentureTHThird Rock Ventures

Climb is a French wealth management service that combines advisors with technology to grow clients' assets through an open-architecture selection of investment products (life insurance, retirement PER, real estate, private equity, tax-reduction schemes, crypto).

FintechSaaS

AEAldric Emié(CEO)in

Co-investorsKIKima VenturesRARA CapitalREREDMILE

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)inRGRonald Goldstein(Executive Officer)inDCDonald Corcoran(Executive Officer, Director)inMRMarkus Renschler(Director)in

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDRDroia VenturesLILightstone VenturesOUOUP (Osage University Partners)DEDe Novo VenturesJAJanus Henderson InvestorsNONovo Holdings+3 more

Elevage Medical appears to be a medical or healthcare company with a team including physicians, board members, and operational staff, though the specific business activities are not detailed on this team page.

Digital HealthHealthtechMedical Devices

EMEvan Melrose(Chief Executive Officer & Partner)inMWMichael Wasserman(Chief Operating Officer & Partner)in

Co-investorsPAPatient Square Capital

Healthcare-enabling research organization that embeds clinical trials into everyday care using electronic health record data.

HealthtechAustin, US

Chad Moore(President)inJPJohn Potthoff(Chief Executive Officer)inJBJacylyn Bodmer(Chief Information Officer)KFKaren Flaherty(Vice President, Finance)inASAmy Staedtler(Chief Legal Officer)inSTScott Treiber(Chief Operating Officer)in

Co-investorsEXExcelerate Health VenturesHAHatteras Venture PartnersNONoro-Moseley PartnersNONorwest Venture PartnersSHShumway Capital

Epic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US

Lei Stanley Qi(Scientific Founder)inASAmber Salzman(Executive Officer, Director)inHaorui Zhang(Executive Officer, Director)

BoardAndrew Lam(Director)Anran Li(Director)Jennifer King(Director)

Co-investorsABabrdn plcANAngelini VenturesFIFidelity InvestmentsJAJanus Henderson InvestorsSASanofi Ventures

Galvanize provides customized technical education and training programs to help enterprise teams build skills in AI, machine learning, XP and Agile practices, data pipelines, and cloud operations.

AI & Machine LearningEdTechEnterprise SoftwareFuture of WorkDenver, US

Christopher C. Onan(Executive Officer)James Deters(President and Chief Executive Officer)LMLawrence Mandes(Managing Director, New Markets)in

BoardDaniel Pianko(Director)Tatiana Goldstein(Director)Jerrold Miller(Director)

Co-investorsSOSofinnova PartnersTETeamworthy VenturesTHThe Colorado Impact FundVTVTF CapitalCACatalyst InvestorsFIFidelity Investments+5 more

Galvanize Climate Solutions is an investment firm focused on the energy transition, deploying capital across areas such as climate risk analytics and clean energy.

CleantechClimate TechEnergy

VMVeery Maxwell(Founder)in

Co-investorsABABS Capital PartnersBLBlue Haven InitiativeGAGalvanize Climate SolutionsFIFidelity InvestmentsGIGilmartin Capital LLCJAJanus Henderson Investors+4 more

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms.

BiotechHealthtechMedical DevicesRedwood City, US

DGDoug Godshall(Executive Officer, Director)inSASteve Anheier(Executive Officer)in

BoardJonathan Waldstreicher(Executive Officer)APAntoine Papiernik(Director)inSeth Harrison(Director)ZSZack Scott(Director)in

Co-investorsNONorwest Venture PartnersATATPFIFidelity InvestmentsGIGilmartin Capital LLCJAJanus Henderson InvestorsPEPerceptive Xontogeny Venture+2 more

GRAIL develops a blood-based multi-cancer early detection test called Galleri that uses next-generation sequencing and machine learning to screen for multiple cancer types before symptoms appear.

BiotechDigital HealthHealthtechMedical DevicesMenlo Park, US

JOJoshua Ofman, MD, MSHS(Chief Executive Officer)in

Co-investorsARARCH Venture Partners6 6 Dimensions CapitalBEBezos ExpeditionsLOLongwood Fund

Shanghai-based, HKEX-listed drug developer commercializing dorzagliatin, the first approved glucokinase activator for type 2 diabetes.

Co-investorsARARCH Venture PartnersF-F-Prime CapitalVEVenrock6 6 Dimensions CapitalBLBlue Pool CapitalEIEight Roads Ventures+2 more

OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.

Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain

Co-investorsOXOxford Investment Opportunity Network (OION)ALAltium CapitalAMAmgen VenturesDRDroia VenturesFRFrazier Healthcare PartnersNONovo Holdings+2 more

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

PIPiers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJBJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)DTDipti Thakkar(Chief Operating Officer)in

Co-investorsALAltium CapitalCLClavystBioDEDecheng CapitalDRDroia VenturesFRFrazier Life SciencesKIKiwoom Investment+6 more

Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.

AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US

AHAaron Hurst(Founder)in

Co-investorsEMEmpire AngelsVOVoyager CapitalAMAmed VenturesASAscension VenturesBABain Capital Life SciencesCACatalio Capital Management+4 more

Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.

HealthtechMedical DevicesTirat Carmel

Roni Karie(Vice President - Finance)SAShirel Aroshase(Vice President - Human Resources)inEZEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJ(Jun (Jim) Tao(Chief Operating Officer)inMRMaurice R. Ferre(Chairman and Chief Executive Officer)in

Co-investorsCACatalio Capital Management, LPEXExigent CapitalGEGEOCJAJazzya InvestmentsKOKoch Disruptive TechnologiesKRKrillion Ventures+7 more

IsoPlexis (now part of Bruker Cellular Analysis) provides single-cell functional profiling technology used to discover therapeutic antibodies, interrogate T cells for novel cell therapies, and accelerate cell line development.

BiotechDeep TechMedical DevicesNew Haven, US

Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)

BoardDaniel Wagner(Director)JCJohn Conley(Director)inGregory Ho(Director)

Co-investorsCOConnecticut InnovationsIRIronwood CapitalNONorthpond VenturesSPSpring Mountain Capital

AdmitHub provides AI-powered success coaching and conversation tools for higher education institutions to improve student engagement, retention, and outcomes.

AI & Machine LearningEdTechHR TechArlington, US

AMANDREW MAGLIOZZI(Executive Officer, Director)inKDKIRK DAULERIO(Executive Officer)inAMAndrew Magliozzi(Founder)in

BoardKEVIN TALBOT(Director)

Co-investorsFUFundersClubMIMichelson 20MM FoundationNXNXT VenturesTETechstarsFOFountain Healthcare PartnersGIGilde Healthcare+6 more

HealthtechPlymouth, US

Dan Sachs(Director)PCPeter Crosby(Executive Officer, Director)inJason Hannonin

BoardManus Rogan(Director)inAPAntoine Papiernik(Director)in

Co-investorsFOFountain Healthcare PartnersIRIreland Strategic Investment FundSOSofinnova PartnersGIGilde HealthcareVIViking Global Investors

Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.

BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US

ELEric Leuthardt(Director)inLPLeo Petrossian(Executive Officer, Director)in

BoardYuanwei Tai(Director)KRKevin Reilly(Director)inFred Khosravi(Director)inStavros Vizirgianakis(Director)

Co-investorsEXExcelestar VenturesAMAmed Ventures

OrbiMed is a global investment firm that manages public equity, private equity, and private credit/royalty strategies focused on the healthcare industry.

BiotechHealthtech

ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics that target toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's.

BiotechDeep TechHealthtechToronto, CA

Neil Cashman, M.D.(Chief Scientific Officer and Co-founder)EUGENE WILLIAMS(Chairman and Co-Founder)inROBERT GUNDEL(Executive Officer, Director)JANET CLENNETT(Executive Officer)inNeil K. Warma(President and Chief Executive Officer)inELLIOT GOLDSTEIN(Executive Officer, Director)

Quantum Surgical develops Epione, a robotic-assisted percutaneous ablation platform that helps interventional radiologists treat inoperable or difficult early-stage tumors without surgery by guiding needle placement for tumor destruction.

AI & Machine LearningMedical DevicesRoboticsMiami, US

BNBertin Nahum(Co-founder & CEO)inChristophe Sibillin(Executive Officer)in

BoardKRKevin Reilly(Director)inChris Geyen(Director)FYFrank Yu(Director)inJoseph DeVivo(Director)

Co-investorsBPBpifrance

SeaGen develops automated robots that monitor aquatic ecosystems and remove pollutants while supporting the growth of beneficial species like seaweed to improve food and water security and reduce atmospheric carbon.

CleantechClimate TechRobotics

Co-investorsAEAera VCRARA CapitalT.T. Rowe Price

Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases.

BiotechHealthtechMedical DevicesSouth San Francisco, US

JBJeffrey Bluestone(Executive Officer, Director, Promoter)inJBJeff Bluestone, PhD(Founder and Scientific Advisor; co-founder and former President and CEO)QTQizhi Tang, PhD(Founder and Scientific Advisor)FRFred Ramsdell, PhD(Founder and Scientific Advisor)ARAlexander Rudensky, PhD(Founder and Scientific Advisor)Stephen Dilly, MBBS, PhD(President and Chief Executive Officer)

Co-investors8V8VCARARCH Venture PartnersFRFrazier Life SciencesJDJDRF T1D FundLALAVLILifeforce Capital+6 more

Strateos develops remote access laboratory software and automation platforms that enable scientists to design, execute, and analyze experiments through cloud-based robotics and control systems.

AI & Machine LearningBiotechDeep TechRoboticsSaaSMenlo Park, US

CKChris Krueger(Executive Officer)inMFMark Fischer-Colbrie(Executive Officer, Director)inDLDavid Lynch, PhD(Chief Executive Officer)MSMarc Siladi(Chief Operating Officer)in

BoardJoshua Wolfe(Director)AVArmen Vidian(Director)in

Co-investorsDCDCVC (Data Collective)LULux CapitalBLBlueStone Venture PartnersTHThird Rock VenturesDODolby Family VenturesHAHarmonix Fund+3 more

Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.

Co-investorsAIAisling CapitalARARCH Venture PartnersQUQuan CapitalALAlexandriaBABain CapitalBABain Capital Life Sciences+6 more

Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™.

AI & Machine LearningBiotechMedical DevicesWatertown, US

TATimothy A. Springer(Co-Founder)Andrew C. Kruse(Director)Alise Reicin(Executive Officer, Director)inDaniel Lochner(Executive Officer)MSMarc Schwabish(Executive Officer)inPMPeter McNamara(Executive Officer)in

Co-investorsECEcoR1 CapitalVIVida VenturesCLClarus VenturesPOPolaris PartnersSOSoleus Capital

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions to help people navigate the healthcare system and access on-demand care.

AI & Machine LearningDigital HealthHealthtech

Co-investorsALAlta PartnersTHThreshold VenturesGEGeneral CatalystGEGeodesic CapitalGRGreatPoint VenturesHUHuman Capital+3 more

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.

AI & Machine LearningDigital HealthHealthtechDenver, US

GTGlen Tullman(Chief Executive Officer)in

Co-investors7W7wire VenturesCOCorewell Health VenturesGEGeneral CatalystGEGeodesic CapitalGRGreatPoint VenturesHUHuman Capital+5 more

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXZXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)RCRob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Co-investorsARARCH Venture PartnersNONorthpond Ventures6 6 Dimensions CapitalAPApplied VenturesKIKilonova CapitalPUPura Vida Investments+3 more

HealthtechSan Jose, US

Greg Vislocky(Director)Charles Chon(Director)Jason Turner(Executive Officer)inPeter Osborne(Executive Officer, Director)Jerry Gibson(Executive Officer, Director)

Vida Health delivers personalized, human-centered digital health care addressing both physical and mental health.

Digital HealthHealthtechSaaSSan Francisco, US

JMJoe Murad(CEO)MRMike Rollain

BoardRFRichard Frank

Co-investorsASAspect VenturesCACanvas VenturesGEGeneral AtlanticHLHLM Venture PartnersNGNGP CapitalOWOwl Capital+5 more

HealthtechCampbell, US

NNNersi Nazari(Executive Officer, Director)inSteve Zadig(Executive Officer, Director)in

BoardRichard Feachem(Director)Tom Saunders(Director)

Co-investorsASAsahi Kasei Corporate Venture CapitalESEssex Woodlands Healthcare PartnersRERevelation PartnersMVMVM Life Science PartnersTRTrinity Capital